EUVIMEDEUVIMED entdecken
Multizentrische StudieVergleichsstudieOpen Access

Lupuslike Manifestations in Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia

Jeanne Chauffier, Vincent Jachiet, Maxime Battistella, Pierre Romero, Pierre Fenaux, Eve Zakine, Lin Pierre Zhao, Thibault Mahévas, Jean-David Bouaziz, Jerome Hadjadj, Zahir Amoura, Alexis Mathian und 14 weitere

JAMA Dermatology · 01.01.2026 · 162 (1) · 31

DOI: 10.1001/jamadermatol.2025.4586 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift JAMA Dermatology, erschienen am 01.01.2026. Verfasst von Jeanne Chauffier und 25 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine Department, Hôpital Saint-Antoine, Assistance Publique-Hôpitaux de Paris, Sorbonne University, Paris, France. Hauptthemen laut MEDLINE: Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic, Lupus Erythematosus, Systemic, Lupus Erythematosus, Cutaneous. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Immune-mediated inflammatory diseases are rare but increasingly reported among patients with myelodysplastic syndromes (MDS) or chronic myelomonocytic leukemia (CMML). Systemic lupus erythematosus (LE) and cutaneous LE associated with MDS/CMML have been rarely described, with atypical features and refractory disease.

Objective

To provide a comprehensive description of the phenotype and therapeutic responses of LE associated with MDS/CMML and to compare them with idiopathic LE. Design, Setting, and Participants This retrospective case-control study included nationwide, multicenter data from January 1975 to January 2023. Patients with MDS/CMML who either fulfilled classification criteria for systemic LE or had skin lesions diagnosed as cutaneous LE were included. For MDS/CMML systemic LE, a 2:1 case-control study was conducted with idiopathic systemic LE. Clinical features, centralized skin histopathology, and targeted next-generation sequencing were analyzed. Data were analyzed from May 2022 to June 2025. Main Outcomes and Measures The clinical, pathological, and molecular features of LE occurring in the setting of MDS or CMML compared with idiopathic LE.

Results

Of 24 included patients, 9 (38%) were female, 15 (63%) were male, and the median (range) age at diagnosis was 65 (32-85) years. A total of 19 were diagnosed with systemic LE and 5 with cutaneous LE. The median (range) follow-up was 4.5 (1-31) years. Cutaneous involvement was the most common manifestation of LE (17 [71%]). Chilblain lupus was the predominant subtype (6 [35%]). Compared with idiopathic systemic LE, patients with MDS/CMML–associated LE were older (median [range] age, 65 [32-85] years vs 23 [11-55] years; P < .001), more frequently male (10 [53%] vs 3 [8%]; P = .008), had less kidney involvement (2 [10%] vs 27 [71%]; P < .001), had less articular involvement (7 [36%] vs 37 [97%]; P < .001), and had reduced anti–double-stranded DNA positivity (6 [32%] vs 29 [76%]; P = .001). The underlying hematologic diseases included MDS (16 [66%]) and CMML (8 [34%]), with 22 (92%) classified as lower risk (Revised International Prognostic Scoring System score of 3.5 or less). Centralized histopathological review reclassified 6 skin biopsies (50%) as MDS/CMML cutis. Identical myeloid variants were detected in blood and skin in 6 of 8 patients, supporting a clonal inflammatory process. Standard LE therapies were often poorly effective, while clone-directed therapies (azacitidine or allogeneic hematopoietic stem cell transplant) led to parallel hematologic and LE responses in 5 of 7 patients. Conclusions and Relevance In this study, MDS/CMML–associated lupuslike manifestations were a distinct entity mimicking systemic LE or cutaneous LE and characterized by clonal inflammation rather than classic autoimmunity in most cases. Early recognition is important, as treatment may require clone-targeting therapies rather than conventional LE therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myelodysplastic SyndromesLeukemia, Myelomonocytic, ChronicLupus Erythematosus, SystemicLupus Erythematosus, CutaneousHumansMaleFemaleRetrospective StudiesAgedMiddle AgedCase-Control StudiesAged, 80 and overAdultSkin

Autor:innen und Institutionen

  • Internal Medicine Department, Hôpital Saint-Antoine, Assistance Publique-Hôpitaux de Paris, Sorbonne University, Paris, France.
  • Pathology Department, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, INSERM U1342, Institut de Recherche Saint-Louis, Université Paris Cité, Paris, France.
  • Pathology Department, Centre Hospitalo-Universitaire de Pitié Salpétrière, CIMI, U11-35 Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Hematology Department, Hopital Saint Louis, Assistance Publique-Hôpitaux de Paris, Université Paris Cité, Paris, France.
  • Dermatology Department, Hopital de Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris Cite University, Paris, France.
  • Internal Medicine Department, Centre Hospitalo-Universitaire de Pitié Salpetrière, Assistance Publique des Hôpitaux de Paris, Sorbonne Université, Paris, France.

Zitieren

APA

Chauffier, J., Jachiet, V., Battistella, M., Romero, P., Fenaux, P., Zakine, E., Zhao, L. P., Mahévas, T., Bouaziz, J. D., Hadjadj, J., Amoura, Z., Mathian, A., Breillat, P., Hirsch, P., Bourguiba, R., De Voeght, A., Grobost, V., Begon, E., Jandus, P., …, & EMSED Group and MINHEMON Group (2026). Lupuslike Manifestations in Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia. JAMA Dermatology, 162(1), 31. https://doi.org/10.1001/jamadermatol.2025.4586

Vancouver

Chauffier J, Jachiet V, Battistella M, Romero P, Fenaux P, Zakine E, et al. Lupuslike Manifestations in Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia. JAMA Dermatology. 2026;162(1):31. doi:10.1001/jamadermatol.2025.4586

BibTeX
@article{Chauffier2026,
  author = {Chauffier, Jeanne and Jachiet, Vincent and Battistella, Maxime and Romero, Pierre and Fenaux, Pierre and Zakine, Eve and Zhao, Lin Pierre and Mahévas, Thibault and Bouaziz, Jean-David and Hadjadj, Jerome and Amoura, Zahir and Mathian, Alexis and Breillat, Paul and Hirsch, Pierre and Bourguiba, Rim and De Voeght, Adrien and Grobost, Vincent and Begon, Edouard and Jandus, Peter and Brenaut, Emilie and Laumondais, Victoire and Fain, Olivier and Moguelet, Philippe and Mekinian, Arsene and Chasset, François and EMSED Group and MINHEMON Group, EMSED Group and MINHEMON Group},
  title = {Lupuslike Manifestations in Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia},
  journal = {JAMA Dermatology},
  year = {2026},
  volume = {162},
  number = {1},
  pages = {31},
  doi = {10.1001/jamadermatol.2025.4586}
}
Kostenlos starten →